Asha Negi returns with web show Khwabon Ke Parindey, says ‘transition from TV to web has been refreshing’

Asha Negi received a lot of accolades for Baarish, a web show where she played an extremely intense character. The actress is now back with a Voot original show titled Khwabon Ke Parindey where she plays Bindiya, a complete wild child who believes in embracing each day as it comes. Asha will be seen alongside Mrinal Dutt, Manasi Moghe & Tushar Sharma in the show. Khwabon Ke Parindey releases on 14th June 2021.

Reminiscing on her friendships and the difference in characters played before, Asha Negi in a statement said, “Khwabon Ke Parindey is a journey of life and hope, but sometimes all you need are close friends to help you rediscover yourself. Bindiya, my character on the show is this complete wild child, who believes in embracing life every single day. When you shoot for a show like this, you tend to relive the moments with your best friends and I did too. However, over a period of time Mrinal, Mansi, Tushar and I got along really well and from being just co-stars we gradually became good friends; making the journey exciting. The entire experience of shooting for the show, made me realise the importance of friends and why it is necessary to have them around you. They are like your truth serum, who help you unravel your deepest secrets and fears and then help you get through it.”

 

View this post on Instagram

 

A post shared by MsNegi (@ashanegi)

She added, “The 60 days of shooting throughout Australia with this amazing young crew has been an unforgettable experience and I would go back to that time in a heartbeat. I thoroughly enjoyed playing Bindiya; although challenging, the transition of my portrayal of roles from television to web has been extremely refreshing. A big thank you to my Rockstar director, Tapasvi Mehta and Voot for giving me this opportunity that has not only challenged me as an actor but as an individual as well.”

Also Read: Asha Negi takes a dig at celebs posting VIDEOS after taking COVID-19 vaccine: Stop overacting, it is annoying